134 related articles for article (PubMed ID: 25070376)
1. Inhibition of the interleukin-23/interleukin-17 pathway by anti-interleukin-23p19 monoclonal antibody attenuates 2,4,6-trinitrobenzene sulfonic acid-induced Crohn's disease in rats.
Yao JY; Lu Y; Zhi M; Li CJ; Hu PJ; Gao X
Mol Med Rep; 2014 Oct; 10(4):2105-10. PubMed ID: 25070376
[TBL] [Abstract][Full Text] [Related]
2. Total glucosides of peony attenuates 2,4,6-trinitrobenzene sulfonic acid/ethanol-induced colitis in rats through adjustment of TH1/TH2 cytokines polarization.
Zhang Y; Zhou R; Zhou F; Cheng H; Xia B
Cell Biochem Biophys; 2014 Jan; 68(1):83-95. PubMed ID: 23771723
[TBL] [Abstract][Full Text] [Related]
3. Dietary n‑3 polyunsaturated fatty acids ameliorate Crohn's disease in rats by modulating the expression of PPAR‑γ/NFAT.
Yao J; Lu Y; Zhi M; Hu P; Wu W; Gao X
Mol Med Rep; 2017 Dec; 16(6):8315-8322. PubMed ID: 28990050
[TBL] [Abstract][Full Text] [Related]
4. Astragalus polysaccharide attenuates rat experimental colitis by inducing regulatory T cells in intestinal Peyer's patches.
Zhao HM; Wang Y; Huang XY; Huang MF; Xu R; Yue HY; Zhou BG; Huang HY; Sun QM; Liu DY
World J Gastroenterol; 2016 Mar; 22(11):3175-85. PubMed ID: 27003994
[TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Clostridium Butyricum in a Murine Model of Dextran Sodium Sulfate-Induced Colitis That Involve Inhibition of the TLR2 Signaling Pathway and T Helper 17 Cells.
Xie Y; Zhou L; Yao X; Li Y
Am J Med Sci; 2020 Aug; 360(2):176-191. PubMed ID: 32553747
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
[TBL] [Abstract][Full Text] [Related]
7. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.
Punkenburg E; Vogler T; Büttner M; Amann K; Waldner M; Atreya R; Abendroth B; Mudter J; Merkel S; Gallmeier E; Rose-John S; Neurath MF; Hildner K
Gut; 2016 Jul; 65(7):1139-50. PubMed ID: 25838550
[TBL] [Abstract][Full Text] [Related]
8. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
Xu J; Zheng C; Huang Y; Liang Y
Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
[TBL] [Abstract][Full Text] [Related]
10. Increased peripheral RORα and RORγt mRNA expression is associated with acute-on-chronic hepatitis B liver failure.
Qi ZX; Wang LY; Fan YC; Zhang JJ; Li T; Wang K
J Viral Hepat; 2012 Nov; 19(11):811-22. PubMed ID: 23043388
[TBL] [Abstract][Full Text] [Related]
11. Development of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis.
Guan Q; Ma Y; Hillman CL; Ma A; Zhou G; Qing G; Peng Z
Vaccine; 2009 Nov; 27(50):7096-104. PubMed ID: 19786142
[TBL] [Abstract][Full Text] [Related]
12. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
[TBL] [Abstract][Full Text] [Related]
13. MFE40-the active fraction of Mume Fructus alcohol extract-alleviates Crohn's disease and its complications.
Liu Z; Peng Y; Zhao L; Li X
J Ethnopharmacol; 2022 Oct; 296():115465. PubMed ID: 35718051
[TBL] [Abstract][Full Text] [Related]
14. Vidofludimus inhibits colonic interleukin-17 and improves hapten-induced colitis in rats by a unique dual mode of action.
Fitzpatrick LR; Small JS; Doblhofer R; Ammendola A
J Pharmacol Exp Ther; 2012 Sep; 342(3):850-60. PubMed ID: 22691298
[TBL] [Abstract][Full Text] [Related]
15. miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease.
Huang Z; Shi T; Zhou Q; Shi S; Zhao R; Shi H; Dong L; Zhang C; Zeng K; Chen J; Zhang J
Gut; 2014 Aug; 63(8):1247-57. PubMed ID: 24000293
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
17. Protective Effect of Thalidomide on 2,4,6-Trinitrobenzenesulfonic Acid-Induced Experimental Colitis in Rats via the Inhibition of T Helper 17 Cells.
Xie Y; Li D; Luan X; Jin S; Yan B; Tian F
Can J Gastroenterol Hepatol; 2020; 2020():8861854. PubMed ID: 32766176
[TBL] [Abstract][Full Text] [Related]
18. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
[TBL] [Abstract][Full Text] [Related]
19. Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.
Yang X; Meng S; Jiang H; Chen T; Wu W
Scand J Gastroenterol; 2010 Oct; 45(10):1168-77. PubMed ID: 20469967
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
